Los Angeles Capital Management’s Kura Oncology KURA Stock Holding History

Los Angeles Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.69K	Sell	823 -22,473	-96%	-$193K	﹤0.01%	2044
2025 Q4	$243K	Sell	23,296 -6,586	-22%	-$69.1K	﹤0.01%	1172
2025 Q3	$264K	Sell	29,882 -48,076	-62%	-$343K	﹤0.01%	1174
2025 Q2	$450K	Buy	+77,958	New	+$478K	﹤0.01%	895
2021 Q1	–	Sell	-11,065	Closed	-$361K	–	1617
2020 Q4	$361K	Sell	11,065 -3,811	-26%	-$134K	﹤0.01%	1319
2020 Q3	$456K	Sell	14,876 -67,314	-82%	-$1.49M	﹤0.01%	1118
2020 Q2	$1.34M	Buy	82,190 +33,315	+68%	+$481K	0.01%	736
2020 Q1	$486K	Buy	48,875 +37,700	+337%	+$432K	﹤0.01%	912
2019 Q4	$154K	Sell	11,175 -150	-1%	-$2.22K	﹤0.01%	1220
2019 Q3	$172K	Hold	11,325	–	–	﹤0.01%	1218
2019 Q2	$223K	Hold	11,325	–	–	﹤0.01%	1270
2019 Q1	$188K	Hold	11,325	–	–	﹤0.01%	1319
2018 Q4	$159K	Sell	11,325 -125	-1%	-$1.66K	﹤0.01%	1219
2018 Q3	$200K	Sell	11,450 -510	-4%	-$9.78K	﹤0.01%	1340
2018 Q2	$218K	Buy	+11,960	New	+$203K	﹤0.01%	1362

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's KURA Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Kura Oncology (KURA) stake by 96% in Q1 2026, selling an estimated $193K and leaving 823 shares worth $6.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Los Angeles Capital Management first reported a position in KURA in Q2 2018 and has held it in 15 quarters since. The position peaked at $1.34M in Q2 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

Los Angeles Capital Management held 823 shares of Kura Oncology worth $6.69K as of Q1 2026.
Los Angeles Capital Management sold 22,473 Kura Oncology shares in Q1 2026, an estimated $193K.
Kura Oncology made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2044 holding.
Los Angeles Capital Management first reported a position in Kura Oncology in Q2 2018 and has held it in 15 quarters since.
Los Angeles Capital Management's Kura Oncology position peaked at $1.34M in Q2 2020.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.